⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 24, 2003Antimicrobial Agents and ChemotherapyOpen Access

Interactions of 1263W94 with Other Antiviral Agents in Inhibition of Human Cytomegalovirus Replication

Dean W. Selleseth Christine L. Talarico Teresa Miller Michael W. Lutz Karen K. Biron

View Full Paper

Ask AI

Bookmark

Share

Abstract

Inhibition of human cytomegalovirus (HCMV) by 1263W94 was additive dosewise in combination with ganciclovir, acyclovir, and foscarnet. None of the commonly used anti-human immunodeficiency virus agents antagonized the inhibition of HCMV by 1263W94. The data were analyzed by a modified isobologram procedure that measures the strength and statistical significance of drug interactions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Selleseth et al. (2003) studied this question.

synapsesocial.com/papers/6a95d6efdb04510482c5d910 https://doi.org/10.1128/aac.47.4.1468-1471.2003

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of ActionOriginal Research · 2002 · 366 citations
2A Statistician's ApologyOriginal Research · 1975 · 22 citations
39-(1,3-Dihydroxy-2-propoxymethyl)guanine: a new potent and selective antiherpes agentIn Vitro Study · 1983 · 341 citations
4Inhibition of Human Cytomegalovirus DNA Maturation by a Benzimidazole Ribonucleoside Is Mediated through the UL89 Gene ProductOriginal Research · 1998 · 192 citations
5Activity of oral β-lactams, tebipenem and ceftibuten, combined with novel oral β-lactamase inhibitors against broad-spectrum β-lactamase-producing Escherichia coliAntimicrobial Agents and Chemotherapy · Wed,

More from Antimicrobial Agents and Chemotherapy

Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinationsWed,
Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones disseminationWed,
A multivalent CPS-CRM197 conjugate vaccine protects against severe/fatal Klebsiella pneumoniae disease in a mouse infection modelWed,
In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infectionsThu,
Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis -derived fungal metabolite targeting pyruvate kinase IITue,